SEC Company Response from Lexaria Bioscience Corp. (LEXX) (CIK 0001348362) (LEXX) — Jul 10, 2006
Lexaria Bioscience Corp. (LEXX) (CIK 0001348362)
Date: July 10, 2006 · CIK: 0001348362 · Accession: 0001137070-06-000226
AI Filing Summary & Sentiment
File numbers found in text: 333-132134
Show Raw Text
CORRESP 1 filename1.htm Blank form Request for Acceleration LEXARIA CORP. #604 - 700 West Pender Street Vancouver, B.C. V6C 1G8 Telephone: (604) 602-1675 BY FAX AND EDGAR July 10, 2006 United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. David Lyon Dear Sir: Re: Lexaria Corp. - Form SB-2 Registration Statement - File No. 333-132134 The undersigned hereby requests, pursuant to Rule 461(a) of the Securities Act of 1933, as amended, that the Effective Date of the above-noted Form SB-2 Registration Statement be accelerated and become effective at 10:00 a.m. (Eastern Standard Time) on Tuesday, July 11, 2006 or as soon thereafter as possible. The undersigned hereby acknowledges that: 1. should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing; 2. the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and 3. the company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. Yours truly, LEXARIA CORP. Per: /s/ "Leonard MacMillan" Leonard MacMillan, President